Health-Related Quality of Life (HRQoL) of Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM) Receiving Any or Lenalidomide (LEN) Maintenance After Autologous Stem Cell Transplant (ASCT) in the Connect® MM Disease Registry

被引：0
|
作者：
Abonour, Rafat [1 ]
Durie, Brian [2 ]
Jagannath, Sundar [3 ]
Shah, Jatin [4 ]
Narang, Mohit [5 ]
Terebelo, Howard [6 ]
Gasparetto, Cristina [7 ]
Toomey, Kathleen [8 ]
Hardin, James [9 ]
Kitali, Amani [10 ]
Gibson, Craig J. [10 ]
Srinivasan, Shankar [10 ]
Swern, Arlene [10 ]
Rifkin, Robert [11 ]
机构：
[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Maryland Oncol Hematol, US Oncol Res, Columbia, MD USA
[6] Providence Canc Inst, Southfield, MI USA
[7] Duke Univ, Hematol Malignancies & Cellular Therapy, Durham, NC USA
[8] Steeplechase Canc Ctr, Somerville, NJ USA
[9] Univ South Carolina, Columbia, SC 29208 USA
[10] Celgene Corp, Summit, NJ USA
[11] Rocky Mt Canc Ctr, US Oncol Res, Denver, CO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-158
引用
收藏
页码：E89 / E90
页数：2
相关论文
共 50 条
  • [1] Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Any or Lenalidomide Maintenance after Autologous Stem Cell Transplant in the Connect MM Disease Registry
    Abonour, Rafat
    Durie, Brian G. M.
    Jagannath, Sundar
    Shah, Jatin J.
    Narang, Mohit
    Terebelo, Howard R.
    Gasparetto, Cristina J.
    Toomey, Kathleen
    Hardin, James W.
    Kitali, Amani
    Gibson, Craig
    Srinivasan, Shankar
    Swern, Arlene S.
    Rifkin, Robert M.
    BLOOD, 2016, 128 (22)
  • [2] HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): THE FIRST TRIAL
    Delforge, M.
    Minuk, L.
    Eisenmann, J. C.
    Arnulf, B.
    Canepa, L.
    Fragasso, A.
    Leyvraz, S.
    Langer, C.
    Ezaydi, Y.
    Vogl, D. T.
    Giraldo-Castellano, P.
    Yoon, S. S.
    Martins, A.
    Zarnitsky, C.
    Escoffre-Barbe, M.
    Lemieux, B.
    Proskorovsky, I.
    Monzini, M. Silva
    Ervin-Haynes, A.
    Houck, V.
    Facon, T.
    HAEMATOLOGICA, 2014, 99 : 109 - 110
  • [3] Treatment outcomes and healthcare resource utilization (HRU) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) with lenalidomide (LEN) only or no maintenance: Connect MM registry.
    Rifkin, Robert M.
    Jagannath, Sundar
    Durie, Brian G.
    Shah, Jatin J.
    Narang, Mohit
    Terebelo, Howard R.
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James W.
    Wagner, Lynne I.
    Parikh, Kejal
    Abouzaid, Safiya
    Srinivasan, Shankar
    Kitali, Amani
    Zafar, Faiza
    Abonour, Rafat
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Impact of post-autologous stem cell transplant (ASCT) maintenance therapy on outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) using the large prospective community-based Connect MM registry.
    Jagannath, Sundar
    Abonour, Rafat
    Durie, Brian G.
    Shah, Jatin J.
    Narang, Mohit
    Terebelo, Howard R.
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James W.
    Wagner, Lynne I.
    Agarwal, Amit
    Srinivasan, Shankar
    Kitali, Amani
    Zafar, Faiza
    Sturniolo, Michael
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Health-related quality of life (HRQOL) in transplant-ineligible patients (pts) with newly diagnosed multiple myeloma (NDMM): Results from the first trial.
    Delforge, Michel
    Minuk, Leonard
    Eisenmann, Jean-Claude
    Arnulf, Bertrand
    Canepa, Letizia
    Fragasso, Alberto
    Leyvraz, Serge
    Langer, Christian
    Ezaydi, Yousef
    Vogl, Dan T.
    Giraldo-Castellano, Pilar
    Yoon, Sung-Soo
    Martins, Angelo
    Zarnitsky, Charles
    Barbe, Martine Escoffre
    Lemieux, Bernard
    Proskorovsky, Irina
    Ervin-Haynes, Annette L.
    Houck, Vanessa
    Facon, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Lenalidomide (LEN) Maintenance Following High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): A Meta-Analysis of Overall Survival (OS)
    McCarthy, Philip
    Holstein, Sarah
    Petrucci, Maria Teresa
    Richardson, Paul
    Hulin, Cyrille
    Tosi, Patrizia
    Bringhen, Sara
    Musto, Pellegrino
    Anderson, Kenneth C.
    Caillot, Denis
    Gay, Francesca
    Moreau, Philippe
    Marit, Gerald
    Jung, Sin-Ho
    Yu, Zhinuan
    Winograd, Benjamin
    Knight, Robert
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E6 - E6
  • [7] Impact of Autologous Stem Cell Transplant (ASCT) Versus Consolidation on Health-Related Quality of Life (HRQoL) for Patients with Multiple Myeloma Receiving Carfilzomib Maintenance: Results from the Cardamon Trial
    Popat, Rakesh
    Wilson, William
    Camilleri, Marquita
    Ramasamy, Karthik
    Streetly, Matthew
    Sive, Jonathan
    Bygrave, Ceri
    Benjamin, Reuben
    Chapman, Michael A.
    Chavda, Selina J.
    Phillips, Beth
    Cuadrado, Maria del Mar
    Pang, Gavin
    Jenner, Richard
    Dadaga, Tushhar
    Kamora, Sumaiya
    de Tute, Ruth M.
    Cavenagh, James
    Clifton-Hadley, Laura
    Owen, Roger G.
    Yong, Kwee
    BLOOD, 2022, 140 : 10191 - 10192
  • [8] Real-World Outcomes for Maintenance Treatment Sequencing after Receiving Lenalidomide, Bortezomib, and Dexamethasone Induction in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Followed By Autologous Stem Cell Transplant (ASCT)
    Fonseca, Rafael
    Parikh, Kejal
    Ung, Brian
    Ni, Quanhong
    Abouzaid, Safiya
    Agarwal, Amit
    BLOOD, 2017, 130
  • [9] Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Improves Health-Related Quality of Life (HRQoL), with Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years Benefiting From Delays in Disease Progression
    Dimopoulos, Meletios Athanasios
    Delforge, Michel
    Hajek, Roman
    Kropff, Martin
    Petrucci, Maria Teresa
    Lewis, Philip
    Millar, Stefanie
    Nang, Jingshan
    Mei, Jay
    Palumbo, Antonio
    BLOOD, 2011, 118 (21) : 1365 - 1365
  • [10] Cost-Effectiveness Analysis of Lenalidomide for Maintenance Therapy after Autologous Stem Cell Transplant (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A United States Payer Perspective
    Zhou, Zheng-Yi
    Parikh, Kejal
    Chai, Xinglei
    Rokito, Ariel
    Udeze, Chuka
    Xie, Jipan
    Agarwal, Amit
    BLOOD, 2018, 132
12345